mcfo The Indian threat is real

[CharlesteApect]

Wkjs Rats ?€?Bop to the Beat?€? of Music
US President Donald Trump visited Saudi Arabia on his first foreign trip since taking office in Januar adidas campus y. During his tour Donald Trump gave a speech about Islam, awkwardly took part in a 'men-only' sword dance and touched a glowing orb. Rest assured, the entire trip gave us a goldmine of tweets and jokes.Trump aims to mend Muslim ties on first foreign tripWhen a Kuch Kuch Hota Hai??song was dubbed over Trump's entrance, reminding all of us of desi weddings..With the right soundtrack, Trump's visit to Riyadh adidas samba og looks like the perfect Asian wedding video #RiyadhSummit pic.twitter.com/y1LfcemS0B— Dr Faraz Ali (@thatdermguy) May 20, 2017The lack of rhythm as Trump took part in a traditional dance... awkward!The look on Tr adidas campus bianche ump's face while handling this sword---> pic.twitter.com/yBAWrTGA9I— Kenneth P. Vogel (@kenvogel) May 20, 2017https://twitter.com/basildabh/status/865992624896921600Arriving at Murabba Palace, Trump briefly participates in traditional Saudi "sword&qu Five Prime could receive $131.5 million-plus from bluebird bio. The collaboration will combine bluebird?€?s lentiviral gene therapy platform and CAR T capabilities with Five Prime?€?s antibodies to what the companies would only call ?€?an undisclosed cancer target for hematologic malignancies and solid tumors.?€?Under their exclusive license agreement, bluebird bio agreed to pay Five Prime $1.5 million upfro yeezy nt, plus more than $130 million per licensed product tied to achieving development, regulatory, and commercial milestones. Five Prime could also receive unspecified tiered royalties on product sales.Bluebird bio agreed to conduct and fund clinical development as well as r new balance 990 egulatory and commercial activities.?€?We feel that bluebird bio is well positioned to succeed with converting Five Prime nike dunks donna 's human antibodies to CAR T cell products that can benefit patients, and we are pleased that our proprietary platform continues to demonstrate its versatility in the field of immuno-oncology," Lewis "Rusty